BioVie Inc. (BIVIW) is a clinical-stage biopharmaceutical company focused on developing innovative drug therapies for neurological and neurodegenerative disorders, as well as advanced liver disease. Headquartered in Carson City, Nevada, BioVie is dedicated to addressing significant unmet medical needs through its proprietary drug candidates, which are designed to enhance patient care and improve health outcomes. With a robust pipeline and experienced leadership, the company aims to drive advancements in therapeutic options, positioning itself as a key player in the evolving biopharmaceutical landscape.